These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 743374)

  • 1. [Guidelines on the use of medicinal plants].
    Battaglino G; Quercia V
    Boll Chim Farm; 1978 May; 117(5):251-7. PubMed ID: 743374
    [No Abstract]   [Full Text] [Related]  

  • 2. [The problem of pesticide and heavy metal residues in plant-derived drugs used in the pharmaceutical industry].
    Lorusso S; Camoni I; Chiacchierini E
    Nuovi Ann Ig Microbiol; 1985; 36(3):169-80. PubMed ID: 3842759
    [No Abstract]   [Full Text] [Related]  

  • 3. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
    Germani C; Montanari L; Petraroja A
    Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
    [No Abstract]   [Full Text] [Related]  

  • 5. [Technical-administrative aspects of the registration of pharmaceutical specialities].
    Marconi M; Battaglino G
    Boll Chim Farm; 1979 Mar; 118(3):118-34. PubMed ID: 475904
    [No Abstract]   [Full Text] [Related]  

  • 6. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ukrainian medicinal plants and their processing].
    Zoz IG; Chernikh NO
    Farm Zh; 1968; 23(2):34-43. PubMed ID: 5731737
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quality of medicinal plant raw material in legislative documents].
    Linchenko MO
    Farm Zh; 1968; 23(4):80-6. PubMed ID: 5704042
    [No Abstract]   [Full Text] [Related]  

  • 9. [The birth of new drugs].
    Petrányi G
    Orv Hetil; 1968 May; 109(21):Suppl:1-6. PubMed ID: 5720715
    [No Abstract]   [Full Text] [Related]  

  • 10. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technicoscientific evolution and current direction of the standards regulating drug registration in Italy and in the European Economic Community].
    Battaglino G
    Boll Chim Farm; 1978 Jun; 117(6):313-24. PubMed ID: 743380
    [No Abstract]   [Full Text] [Related]  

  • 12. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 13. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality assurance in proprietary medicines.
    Clarke CL
    Med Serv J Can; 1967 Mar; 23(3):277-86. PubMed ID: 6056373
    [No Abstract]   [Full Text] [Related]  

  • 15. Negotiating reality: the construction of enforceable pharmaceutical standards.
    Parrish RH
    Food Drug Law J; 2002; 57(3):457-74. PubMed ID: 12710406
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward more effective drug regulation.
    Schmidt AM
    FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532
    [No Abstract]   [Full Text] [Related]  

  • 17. [Responsibility for drug testing and control].
    Büchi J
    Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866
    [No Abstract]   [Full Text] [Related]  

  • 18. America's first drug regulation regime: the rise and fall of the Import Drug Act of 1848.
    Heath WJ
    Food Drug Law J; 2004; 59(1):169-99. PubMed ID: 15212037
    [No Abstract]   [Full Text] [Related]  

  • 19. [Private enterprise provides better and safer drugs].
    Monvall E
    Vardfacket; 1979 Mar; 3(6):17-8. PubMed ID: 258054
    [No Abstract]   [Full Text] [Related]  

  • 20. [Harmful effects of drugs. Liability of the manufacturers against insurance claims for damages].
    Dahl B
    Ugeskr Laeger; 1984 Sep; 146(36):2726-8. PubMed ID: 6515894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.